Exact Mass: 365.1964034
Exact Mass Matches: 365.1964034
Found 472 metabolites which its exact mass value is equals to given mass value 365.1964034
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Senkirkin
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 178 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 168 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 158 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 148 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 138 INTERNAL_ID 138; CONFIDENCE Reference Standard (Level 1) CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 128 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 118 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 108 INTERNAL_ID 2283; CONFIDENCE Reference Standard (Level 1) CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2283
Trimethaphan
Trimethaphan is only found in individuals that have used or taken this drug. It is a nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery. [PubChem]Trimethaphan is a ganglionic blocking agent prevents stimulation of postsynaptic receptors by competing with acetylcholine for these receptor sites. Additional effects may include direct peripheral vasodilation and release of histamine. Trimethaphans hypotensive effect is due to reduction in sympathetic tone and vasodilation, and is primarily postural. C - Cardiovascular system > C02 - Antihypertensives > C02B - Antiadrenergic agents, ganglion-blocking > C02BA - Sulfonium derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents
Ondansetron hydrochloride
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D003879 - Dermatologic Agents > D000982 - Antipruritics D002491 - Central Nervous System Agents
Propericiazine
C21H23N3OS (365.15617480000003)
Propericiazine is a phenothiazine of the piperidine group. It has been shown to reduce pathologic arousal and affective tension in some psychotic patients, while the symptoms of abnormal mental integration are relatively unaffected. It is a sedative phenothiazine with weak antipsychotic properties. It also has adrenolytic, anticholinergic, metabolic and endocrine effects and an action on the extrapyramidal system. It is used as an adjunctive medication in some psychotic patients, for the control of residual prevailing hostility, impulsiveness and aggressiveness. Pericyazine, like other phenothiazines, is presumed to act principally in the subcortical areas, by producing what has been described as a central adrenergic blockade. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pericyazine (Propericiazine) is a first-generation antipsychotic agent that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine is a selective D2-dopamine receptor antagonist[2][3]. Pericyazine has adrenolytic, anticholinergic, and extrapyramidal effects[4].
Brevianamide B
Brevianamide A is a mycotoxin from Penicillium brevi-compactum and some other Penicillium specie
Aegle marmelos Alkaloid C
Aegle marmelos Alkaloid C is found in fruits. Aegle marmelos Alkaloid C is an alkaloid from leaves of Aegle marmelos (bael). Alkaloid from leaves of Aegle marmelos (bael). Aegle marmelos Alkaloid C is found in fruits.
Isopentenyladenine-9-N-glucoside
Isopentenyladenine-9-N-glucoside belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Isopentenyladenine-9-N-glucoside is a strong basic compound (based on its pKa). Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. [HMDB]
5-O-Desmethyldonepezil
5-O-Desmethyldonepezil is only found in individuals that have used or taken Donepezil. 5-O-Desmethyldonepezil is a metabolite of Donepezil. 5-o-desmethyldonepezil belongs to the family of Indanones. These are compounds containing an indane ring bearing a ketone group.
6-O-Desmethyldonepezil
6-O-Desmethyldonepezil is only found in individuals that have used or taken Donepezil. 6-O-Desmethyldonepezil is a metabolite of Donepezil. 6-o-desmethyldonepezil belongs to the family of Indanones. These are compounds containing an indane ring bearing a ketone group.
Nequinate
C22H23NO4 (365.16269980000004)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent Antiprotozoan; used as a coccidiostat for poultry and rabbit
Caroverine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Florbenazine
Riddelliine N-oxide
Timegadine
C20H23N5S (365.16740780000003)
Nafadotride
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists
Erucifoline N-oxide
A pyrrolizine alkaloid that is erucifoline in which the tertiary amino function has been oxidised to the corresponding N-oxide. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2256
2-(3,4-Diguanidinobutanoylamino)-3-(4-hydroxyphenyl)propionic acid
C15H23N7O4 (365.18114380000003)
3alpha-(O-methylitaconyl)-6beta-angeloyloxytropane|Schizanthine G
1-methylzeatine riboside|6-(4-hydroxy-1,3-dimethylbut-trans-2-enylamino)-9-beta-D-ribofuranosylpurine
9-Hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.04,8.016,19]nonadec-13-ene-3,6,10-trione
6-(4-Methoxyphenyl)-7-(3,4-dimethoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizine
5alpha,12-dihydroxy-1-tremulen-11-yl 2(S)-pyroglutamate
(3Z)-8a-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene}hexahydropyrrolo[1,2-a]pyrazine-1,4-dione|brevianamide Q
3alpha-(O-methylitaconyl)-6beta-senecioyloxytropane
3alpha-(O-methylmesaconyl)-6beta-senecioyloxytropane
Renardin
Senkirkine is a macrolide. Senkirkine is a natural product found in Tussilago farfara, Senecio gallicus, and other organisms with data available. See also: Petasites hybridus root (part of); Tussilago farfara flower (part of); Tussilago farfara leaf (part of).
Isopentenyl-Adenine-9-glucoside
Acquisition and generation of the data is financially supported by the Max-Planck-Society
Isopentenyl-Adenine-7-glucoside
Acquisition and generation of the data is financially supported by the Max-Planck-Society
isopentenyl-Adenine-7-glucoside-[d6]
Acquisition and generation of the data is financially supported by the Max-Planck-Society
isopentenyl-Adenine-9-glucoside-[d6]
Acquisition and generation of the data is financially supported by the Max-Planck-Society
Periciazine
C21H23N3OS (365.15617480000003)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pericyazine (Propericiazine) is a first-generation antipsychotic agent that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine is a selective D2-dopamine receptor antagonist[2][3]. Pericyazine has adrenolytic, anticholinergic, and extrapyramidal effects[4].
(S)-3-((6-hydroxy-2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl)methyl)-2,3,6,7-tetrahydropyrrolo[1,2-a]pyrazine-1,4-dione
JWH 250 N-(5-carboxyxypentyl) metabolite
C22H23NO4 (365.16269980000004)
5-O-Desmethyldonepezil
A member of the class of piperidines that is donepezil in which the 5-methoxy group has been demethylated to the corresponding hydroxy derivative. It is metabolite of donepezil, a drug used in the treatment of dementia.
6-O-Desmethyldonepezil
Brevianamide B
Statyl
C22H23NO4 (365.16269980000004)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Aegle marmelos Alkaloid C
1-(Dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-ol hydrochloride
C20H28ClNO3 (365.17576080000003)
6-([1,4]BIPIPERIDINYL-1-SULFONYL)-BENZOTRIAZOL-1-OL
C16H23N5O3S (365.15215280000007)
2-Propanol, 1-((6-methoxy-9H-pyrido(3,4-b)indol-4-yl)oxy)-3-((1-methyl ethyl)amino)-, hydrochloride
Basic Violet 2
C22H24ClN3 (365.16586540000003)
D004396 - Coloring Agents > D012394 - Rosaniline Dyes
potassium,dodecane-1-thiol,prop-2-enenitrile,prop-2-enoate
2-(4-BOC-PIPERAZINYL)-2-(3-NITRO-PHENYL)ACETIC ACID
Timegadine
C20H23N5S (365.16740780000003)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
3-N-BOC-AMINO-1-[2-AMINO-1-(2,5-DIMETHOXY-PHENYL)-ETHYL]-PYRROLIDINE
C19H31N3O4 (365.23144460000003)
3-N-BOC-AMINO-1-[2-AMINO-1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-PYRROLIDINE
C19H31N3O4 (365.23144460000003)
tert-butyl 1-(4-(2-phenylacetyl)phenyl)cyclobutylcarbamate
2-[bis(2-hydroxyethyl)amino]ethanol,2-butoxyethanol,phosphoric acid
Prexasertib
C18H19N7O2 (365.16001539999996)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-fluorophenyl)- (9CI)
Urea, N-[2-[(3-cyano-6,8-dimethyl-2-quinolinyl)amino]ethyl]-N-cyclohexyl- (9CI)
A 77636 hydrochloride
C20H28ClNO3 (365.17576080000003)
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists A-77636 hydrochloride is a potent, orally active, selective and long acting dopamine D1 receptor agonist (pKi=7.40; Ki=39.8 nM) with antiparkinsonian activity. A-77636 hydrochloride is functionally inactive at dopamine D2 receptor[1][2].
(1S,2R)-1-[(3,5-DI-TERT-BUTYL-2-HYDROXYBENZYLIDENE)AMINO]-2-INDANOL
(s)-tert-butyl 1-(tert-butyldimethylsilyloxy)-3-phenylpropan-2-ylcarbamate
C20H35NO3Si (365.23860800000006)
Micafungin Side Chain Methyl Ester
C22H23NO4 (365.16269980000004)
2-(5-Norborene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium tetrafluoroborate
C14H20BF4N3O3 (365.15337680000005)
(1R,2S)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYL-1-PROPANOL
C22H23NO4 (365.16269980000004)
(1S,2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)cyclohexane-1-carboxylic acid
C22H23NO4 (365.16269980000004)
(1S,2R)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYL-1-PROPANOL
C22H23NO4 (365.16269980000004)
(3R,4R,5S)-4-(4-HYDROXYPHENYL)-5-((TRIISOPROPYLSILYL)OXY)PIPERIDIN-3-OL
C20H35NO3Si (365.23860800000006)
2-[1-(9H-fluoren-9-ylmethoxycarbonylamino)cyclopentyl]acetic acid
C22H23NO4 (365.16269980000004)
3-Fluoro-4-cyanophenyl trans-4-(4-n-propylcyclohexyl)-benzoate
1-(1-ANTHRACENYLMETHYL)-4-(3-METHOXYPHENYL)-1H-[1,2,3]TRIAZOLE
C24H19N3O (365.15280440000004)
[10-[(4-phenyltriazol-1-yl)methyl]anthracen-9-yl]methanol
C24H19N3O (365.15280440000004)
3-[4-(Hexyloxy)phenyl]-3-({[(2-methyl-2-propanyl)oxy]carbonyl}ami no)propanoic acid
3-(TRIFLUOROMETHYL)[1,1-BIPHENYL]-4-SULFONYLCHLORIDE
(1R,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID
C22H23NO4 (365.16269980000004)
1-(4-[PHENYLAZO]PHENYLAZO)-2-METHYLAMINONAPHTHALENE
METHYL4-((5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)CARBAMOYL)BENZOATE
(1R,2S)-1-[(3,5-DI-TERT-BUTYL-2-HYDROXYBENZYLIDENE)AMINO]-2-INDANOL
4-[(3-Methyl-1-benzothiophen-2-yl)methyl]-N-(3-pyridinyl)-1-piper idinecarboxamide
C21H23N3OS (365.15617480000003)
[4-[2-(diethylamino)ethoxy]phenyl]-(2-ethyl-1-benzofuran-3-yl)methanone
1-O-tert-butyl 4-O-ethyl 4-[(4-fluorophenyl)methyl]piperidine-1,4-dicarboxylate
C20H28FNO4 (365.20022600000004)
2-(4-BOC-PIPERAZINYL)-2-(2-NITRO-PHENYL)ACETIC ACID
1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium acetate
1-(Fmoc-amino)cyclohexanecarboxylic acid
C22H23NO4 (365.16269980000004)
(αS)-α-[[(1R)-2-Hydroxy-1-phenylethyl]aMino]-tricyclo[3.3.1.1(3,7)]decane-1-acetic acid hydrochloride
C20H28ClNO3 (365.17576080000003)
{3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}Methanol
(2R,4S)-4-([1,1-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid
C22H23NO4 (365.16269980000004)
3-fmoc-amino-cyclohexanecarboxylic acid
C22H23NO4 (365.16269980000004)
(1S,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID
C22H23NO4 (365.16269980000004)
2-Methoxy-5-[[[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]benzoic acid methyl ester
(R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-2-yl)
C22H23NO4 (365.16269980000004)
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-cyclobutyl
C22H23NO4 (365.16269980000004)
5,6-bis[4-(dimethylamino)phenyl]-2-methyl-1,2,4-triazine-3-thione
C20H23N5S (365.16740780000003)
(S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-1,2,3,4-tetrahydroisoquinoline
Riddelliine N-oxide
A pyrrolizine alkaloid that is 13,19-didehydrosenecionane bearing two additional hydroxy substituents at positions 12 and 18, two additional oxo groups at positions 11 and 16 and an N-oxido substituent.
4-[(E)-(5-Piperidin-1-ylfuran-2-yl)methylideneamino]spiro[4-azatricyclo[5.2.1.02,6]dec-8-ene-10,1-cyclopropane]-3,5-dione
5-[2-(1-Azepanyl)-2-oxoethyl]-1-(4-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinone
1-[[4-(2,4,6-Trimethylphenyl)-1-piperazinyl]sulfonyl]azepane
2-methyl-N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]propanamide
JWH 250 N-pentanoic acid metabolite
C22H23NO4 (365.16269980000004)
2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide
2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine
C19H19N5O3 (365.14878239999996)
5-Chloro-1H-indole-2-carboxylic acid{[cyclopentyl-(2-hydroxy-ethyl)-carbamoyl]-methyl}-amide
HG9A-9, Nonanoyl-N-hydroxyethylglucamide
C17H35NO7 (365.24134000000004)
Caroverine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
3-cyclohexyl-N-{3-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]phenyl}propanamide
2-(5-Chloro-2-morpholin-4-ylanilino)-1-(3-methylpiperidin-1-yl)propan-1-one
C19H28ClN3O2 (365.18699380000004)
7-(alpha-D-glucosyl)-N(6)-isopentenyladenine
A glucosyl-N(6)-isopentenyladenine in which the glucosyl moiety is in the pyranose form, has alpha-D-configuration and is located at position N-7.
(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]-4-methylpentanoic acid
(2S,9S)-10,10-dimethylspiro[1H-indole-2,11-3,13-diazatetracyclo[5.5.2.01,9.03,7]tetradecane]-2,3,14-trione
(4E)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-14-oxido-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione
Cathestatin B
A carboxamide obtained by the formal condensation of the carboxylic group of oxirane-2,3-dicarboxylic acid with the amino group of N-(4-aminobutyl)-L-tyrosinamide (the 2S,3S stereoisomer). An antibiotic isolated from the fermentation broth of Penicillium citrinum, it acts as a potent inhibitor of cysteine protease.
N-butyl-N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-2-pyridinecarboxamide
N-(2-aminophenyl)-4-hydroxy-2-oxo-1-pentyl-3-quinolinecarboxamide
2-[(1-Methyl-3-indolyl)thio]-1-(4-phenyl-1-piperazinyl)ethanone
C21H23N3OS (365.15617480000003)
(2R,4S)-2-(3-((phenylcarbamoyl)methylcarbamoyl)propyl)-4-aminopentanedioic acid
7-(4-Ethoxyphenyl)-5-(3-methoxyphenyl)-1,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine
N-[2-(4-Isobutyryl-piperazin-1-yl)-phenyl]-4-methyl-benzamide
N-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-3-(2-methylphenoxy)propanamide
5-(4-fluorophenyl)-N-[2-(1-piperidinyl)phenyl]-4-oxazolecarboxamide
2-[[3-Acetyl-1-[4-(dimethylamino)phenyl]-2-methyl-5-indolyl]oxy]acetamide
1-[1-[(4-Fluorophenyl)methyl]-5-methyl-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea
[[4-(Dimethylamino)phenyl]-(2-methylpropoxy)phosphoryl]-(2-fluorophenyl)methanol
C19H25FNO3P (365.15560020000004)
4-hydroxy-2-oxo-1-pentyl-N-(pyridin-2-ylmethyl)-1,2-dihydroquinoline-3-carboxamide
4-[(2E)-2-(3-allyl-2-hydroxybenzylidene)hydrazino]-N-(4-methylphenyl)-4-oxobutanamide
18-hydroxycarbocyclic thromboxane A2(1-)
C21H33O5- (365.23278680000004)
[1-[(1-Ethyl-4-pyrazolyl)methyl]-3-piperidinyl]-[3-(trifluoromethyl)phenyl]methanone
N-(2-cyclohexylidene-1-phenylethyl)-1,1-diphenylmethanimine
jacozine N-oxide
A pyrrolizine alkaloid that is jacozine in which the tertiary amino function has been oxidised to the corresponding N-oxide.
(2R,3R,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
3-[4-[(1R,5S)-3-(phenylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile
(2R,3S,4S)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile
C21H23N3OS (365.15617480000003)
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2S,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2S,3R,4R)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile
C21H23N3OS (365.15617480000003)
(2S,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(1S,9R,10R,11R)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1S,5R)-7-[4-(4-methoxyphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide
(2S,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2S,3S,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(1R,9S,10S,11S)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
beta-D-Tyvp-(1->3)-beta-D-GalpNAc-OMe
C15H27NO9 (365.16857319999997)
(5R,7S,9Z,12R,15R,18R)-9-ethylidene-7-(hydroxymethyl)-5-methyl-15-oxido-3,6,11-trioxa-15-azoniatetracyclo[10.5.1.05,7.015,18]octadec-1(17)-ene-4,10-dione
(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid
1,1-Dimethyl-4-trimethylsilyl-5-phenyl-3-(o-tolyl)-1,3-disila-4-cyclopentene
TRIMETHAPHAN
C - Cardiovascular system > C02 - Antihypertensives > C02B - Antiadrenergic agents, ganglion-blocking > C02BA - Sulfonium derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents
Nequinate
C22H23NO4 (365.16269980000004)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
(2S,3R,4E)-2-aminoheptadec-4-ene-1,3-diol-1-phosphate
5'-O-TBDMS-dA
5'-O-TBDMS-dA is a modified nucleoside and can be used to synthesize DNA or RNA.
9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
(8as)-6-(3,4-dimethoxyphenyl)-7-(4-methoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizine
(20r,21s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol
C22H23NO4 (365.16269980000004)
8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one
C22H23NO4 (365.16269980000004)
1-methyl (1r,3r,5s,6r)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2z)-2-methylbut-2-enedioate
6-(3,4-dimethoxyphenyl)-7-(4-methoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizine
(3z,8ar)-1,8a-dihydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one
(2s)-2-{[(3r)-3,4-dicarbamimidamido-1-hydroxybutylidene]amino}-3-(4-hydroxyphenyl)propanoic acid
C15H23N7O4 (365.18114380000003)
5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol
C22H23NO4 (365.16269980000004)
1-methyl (1r,3r,5s,6r)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-6,10-diol
C22H23NO4 (365.16269980000004)
1-methyl (1r,3r,5s,6r)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate
(1r,4e,6s,7r,11z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
1-methyl (1r,3r,5s,6r)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate
(2s,3s,4r,5s,6r)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxane-3,4,5-triol
(7s)-6',7'-dimethoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]
C22H23NO4 (365.16269980000004)
11α-hydroxy-acetylfawcettine
{"Ingredient_id": "HBIN000348","Ingredient_name": "11\u03b1-hydroxy-acetylfawcettine","Alias": "NA","Ingredient_formula": "C20H31NO5","Ingredient_Smile": "CC1CC23C4CCCN2CCC(C3C(C1OC(=O)C)CC4OC(=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38581","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(20s,21s)-10,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,21-diol
C22H23NO4 (365.16269980000004)
1-methyl (1s,3s,5r,6s)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate
1-methyl 8-methyl-6-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
(1r,4z,6s,7r,11z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
2-hydroxy-2-{[4-(1-hydroxyocta-2,4-dien-1-ylidene)-1-methyl-3,5-dioxopyrrolidin-2-yl]methyl}-3-methylbutanoic acid
(2r,3r,4s,5r)-2-(6-{[(2r,3e)-5-hydroxy-4-methylpent-3-en-2-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(1r,4z,6r,7s,11z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
(1r,2r,4as,8s,8as)-8-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-1-isocyano-2-methyl-5-methylidene-octahydronaphthalen-2-ol
(5e)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one
C22H23NO4 (365.16269980000004)
8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,6-dien-4-one
C22H23NO4 (365.16269980000004)
(2e,4e,6e)-7-{10-[(1e,3e)-4-(c-hydroxycarbonimidoyl)buta-1,3-dien-1-yl]-3-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,8-dien-2-yl}hepta-2,4,6-trienoic acid
C22H23NO4 (365.16269980000004)
(1's,2r,3'r,7's)-13'-hydroxy-4',4'-dimethyl-1h-9',14'-diazaspiro[indole-2,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-3,8'-dione
1-methyl 8-methyl-6-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enedioate
(20s,21r)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol
C22H23NO4 (365.16269980000004)
(1's,3s,3'r,7's)-2,13'-dihydroxy-4',4'-dimethyl-9',14'-diazaspiro[indole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-8'-one
(1s,4z,6r,7r)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
13'-hydroxy-4',4'-dimethyl-1h-9',14'-diazaspiro[indole-2,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-3,8'-dione
(20s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-6,10-diol
C22H23NO4 (365.16269980000004)
1-methyl (1s,3s,5r,6s)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
(5z)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,5-dien-4-one
C22H23NO4 (365.16269980000004)
4-({[(3r,3ar,4s,6ar,8s,9ar,9bs)-4,8-dihydroxy-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}amino)butanoic acid
(2s,3's)-13'-hydroxy-4',4'-dimethyl-1h-9',14'-diazaspiro[indole-2,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-ene-3,8'-dione
6-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate
C22H23NO4 (365.16269980000004)
1-methyl (1r,3r,5s,6r)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
2-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]cyclopropane-1-carboxylic acid
(1r,4z,7s,17r)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate
(4z,11z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
(2e)-n-[(2s)-2-methoxy-2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl]-3-phenylprop-2-enimidic acid
1,8a-dihydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one
2-[(3,4-dicarbamimidamido-1-hydroxybutylidene)amino]-3-(4-hydroxyphenyl)propanoic acid
C15H23N7O4 (365.18114380000003)
1-methyl (1r,3r,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2z)-2-methylbut-2-enedioate
(5r,7s,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-4,10-dioxo-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-en-15-ium-15-olate
2-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]cyclopropane-1-carboxylic acid
(1r,20r)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione
7-hydroxy-5-methoxy-8-(1-methylpiperidin-2-yl)-2-phenylchromen-4-one
C22H23NO4 (365.16269980000004)
(1'r,3s,6's,7'r,17'r)-7'-hydroxy-3,7'-dimethyldispiro[oxirane-2,4'-[2,9]dioxa-[14]azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-6',2''-oxiran]-11'-ene-3',8'-dione
(2s,3s)-3-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
1-methyl (1s,3s,5r,6s)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate
2-hydroxy-2-{[(2r)-4-(1-hydroxyocta-2,4-dien-1-ylidene)-1-methyl-3,5-dioxopyrrolidin-2-yl]methyl}-3-methylbutanoic acid
(6s,6ar,10r,10as)-2-methoxy-10-methyl-4-phenyl-6-[(1e)-prop-1-en-1-yl]-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
3-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid
(1r,4s,7s,11z)-4-ethyl-7-hydroxy-7,14-dimethyl-6-methylidene-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
(8ar)-7-(3,4-dimethoxyphenyl)-6-(4-methoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizine
(10s)-9-hydroxy-10-isopropyl-7-{[(2e)-3-oxo-1h-indol-2-ylidene]methyl}-5,8-diazatricyclo[5.2.2.0¹,⁵]undec-8-en-6-one
(2s)-2-hydroxy-2-{[(2s,4z)-4-[(2e,4e)-1-hydroxyocta-2,4-dien-1-ylidene]-1-methyl-3,5-dioxopyrrolidin-2-yl]methyl}-3-methylbutanoic acid
7-(3,4-dimethoxyphenyl)-6-(4-methoxyphenyl)-1,2,3,5,8,8a-hexahydroindolizine
(1s,2s)-2-{[(1s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}cyclopropane-1-carboxylic acid
2-methoxy-10-methyl-4-phenyl-6-[(1e)-prop-1-en-1-yl]-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
6-methyl-1-{[3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]methyl}-9h-carbazole-2,7-diol
n-[(1r,4r,4as,8ar)-4-[6-(2-chloropropan-2-yl)-5,6-dihydro-2h-pyran-3-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalen-1-yl]carboximidic acid
1-methyl (1s,3s,5r,6s)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
4-ethyl-7-hydroxy-7,14-dimethyl-6-methylidene-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
6',7'-dimethoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]
C22H23NO4 (365.16269980000004)
(1r,7s)-9-hydroxy-11-isopropyl-7-{[(2z)-3-oxo-1h-indol-2-ylidene]methyl}-5,8-diazatricyclo[5.2.2.0¹,⁵]undec-8-en-6-one
1-methyl (1r,3r,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate
1-methyl (3r,6r)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
2-{[2-({2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene}amino)-1-hydroxypropylidene]amino}-4-methylpentanoic acid
(6e)-8-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)-2,6-dimethylocta-2,6-dien-4-one
C22H23NO4 (365.16269980000004)
[7-hydroxy-5-(hydroxymethyl)-2,2,8-trimethyl-3,5,6,7,8,8a-hexahydro-1h-azulen-4-yl]methyl 5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate
1-methyl 8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enedioate
7-[10-(4-carbamoylbuta-1,3-dien-1-yl)-3-oxatricyclo[5.3.1.0⁴,¹¹]undeca-5,8-dien-2-yl]hepta-2,4,6-trienoic acid
C22H23NO4 (365.16269980000004)
(20s)-6,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,10-diol
C22H23NO4 (365.16269980000004)
(1s,4e,6r,7r)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
10,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,21-diol
C22H23NO4 (365.16269980000004)
2-{6-[(5-hydroxy-4-methylpent-3-en-2-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol
2,13'-dihydroxy-4',4'-dimethyl-9',14'-diazaspiro[indole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-8'-one
(20s,21s)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-10,21-diol
C22H23NO4 (365.16269980000004)
(1r,4r,5r,8s,9s,19r)-9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
(1s,20s)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione
(1s,2s)-2-{[(1s,2s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl]-c-hydroxycarbonimidoyl}cyclopropane-1-carboxylic acid
(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene]amino}-1-hydroxypropylidene]amino}-4-methylpentanoic acid
2-methoxy-10-methyl-4-phenyl-6-(prop-1-en-1-yl)-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-one
[(5r,7r,8s,8ar)-7-hydroxy-5-(hydroxymethyl)-2,2,8-trimethyl-3,5,6,7,8,8a-hexahydro-1h-azulen-4-yl]methyl (2r)-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate
(1r,4z,6r,7r)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
(1'r,3s,3'r,7'r)-2,13'-dihydroxy-4',4'-dimethyl-9',14'-diazaspiro[indole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-8'-one
1-methyl (1s,3r,5s)-8-methyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
(3z)-1,8a-dihydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one
1-methyl 8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylidenebutanedioate
n-(2-methoxy-2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)-3-phenylprop-2-enimidic acid
(1r,4e,6r,7r,11z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione
(1r,3r,5s,6r)-6-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate
C22H23NO4 (365.16269980000004)
(2s)-2-hydroxy-2-{[(2s)-4-(1-hydroxyocta-2,4-dien-1-ylidene)-1-methyl-3,5-dioxopyrrolidin-2-yl]methyl}-3-methylbutanoic acid
6-methyl-1-{[(2s,3s)-3-methyl-3-(4-methylpent-3-en-1-yl)oxiran-2-yl]methyl}-9h-carbazole-2,7-diol
2-hydroxy-2-({5-hydroxy-1-methyl-4-[(2e,4e)-octa-2,4-dienoyl]-3-oxo-2h-pyrrol-2-yl}methyl)-3-methylbutanoic acid
(1r,2r,4as,8s)-8-[(2r,5s)-5-chloro-2,6,6-trimethyloxan-2-yl]-1-isocyano-2-methyl-5-methylidene-octahydronaphthalen-2-ol
6,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene-5,10-diol
C22H23NO4 (365.16269980000004)